Compare ETFs
Up to five funds side by side — fees, size, yields, performance, risk, top holdings and sector mix, with a normalized total-return chart.
| Metric |  CANC Tema Oncology ETF |
|---|---|
| Price | 44.84 -1.03% |
| Issuer | Tema |
| AUM | $218.5M |
| Expense Ratio | 0.99% |
| Yield (TTM) | 0.04% |
| Inception | Aug 14, 2023 |
| Holdings | 59 |
| Avg Volume | 30.36K |
| YTD | +29.16% |
| 1Y total | +67.56% |
| 3Y total (ann.) | +22.95% |
| 5Y total (ann.) | — |
| Volatility 1Y | 22.85% |
| Sharpe 1Y | 3.00 |
| Max drawdown 1Y | -9.29% |
| Beta vs S&P 500 (3Y) | 0.774 |
| Top 10 holdings | RVMD 5.96% LLY 5.44% COGT 4.79% RHHBY 4.39% NOVN.SW 3.84% MRK 3.57% BMY 3.48% ABBV 3.34% ONC 3.22% HALO 3.15% |
| Sector mix | Healthcare 100.00% |
Total Return — normalized
Dividend-adjusted daily closes over the last 12 months, normalized to 0% at the range start.
Market data delayed approximately 15–20 minutes unless otherwise indicated. Comparison presents measurable characteristics only — it is not advice about which fund suits anyone.